Clinical Trial Update: Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer [NA]

View source ↗

Summary

The document reports a completed neoadjuvant trial evaluating cetuximab with fluorouracil and pelvic irradiation for locally advanced or locally recurrent recta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (Adrucil) (5-Fluorouracil)
• Cetuximab (Erbitux) (Cetuximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer | NA | Status: COMPLETED